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Abstract 
Ex vivo wounded human skin organ culture is an invaluable tool for translationally relevant 
preclinical wound healing research. However, studies incorporating this system are still 
under-utilized within the field, due to the low throughput of histological analysis required for 
downstream assessment. In this study we use intravital fluorescent dye to lineage trace 
epidermal cells, demonstrating that wound re-epithelialization of human ex vivo wounds 
occurs consistent with an extending shield mechanism of collective migration. Moreover, we 
also report a relatively simple method to investigate global epithelial closure of explants in 
culture using daily fluorescent dye treatment and en face imaging. This study is the first to 
quantify healing of ex vivo wounds in a longitudinal manner, providing global assessments 
for re-epithelialisation and tissue contraction. We show that this approach can identify 
alterations to healing with a known healing promoter. This methodological study highlights 
the utility of human ex vivo wounds in enhancing our understanding of mechanisms of human 
skin repair and in evaluating novel therapies to improve healing outcome. 
 
 
 
 
 
 
 
 
Introduction 
Experimentally wounded human skin organ culture has proven to be an invaluable tool for 
translationally relevant preclinical research for the past 20 years (1). Many different groups 
have now developed similar approaches to understand basic mechanisms of human wound 
healing and for identifying novel candidate wound healing promoters (2-8). In addition, 
assays using porcine skin ex vivo have been established (9-11), due to its anatomical 
similarity and strong concordance with human healing (12). Reconstituted skin cultures (also 
known as organotypic or skin equivalent cultures), which comprise keratinocytes seeded onto 
a fibroblast containing collagen gel, are also available to model human wounds (13-15). Both 
skin explant and skin equivalent approaches display epithelial migration across the 
underlying matrix to heal the wound, although ex vivo skin is thought to mimic the in vivo 
situation more closely (16, 17). Injury to artificial skin equivalent cultures initiates collective 
cell migration and wounds re-epithelialize through the formation of an extending shield (14), 
though resolving whether this same mechanism is conserved in the much more complex 
environment found in human skin is yet to be addressed.  
The accurate measurement of wound re-epithelialization in 3D experimental models has 
proved challenging due to high workload required to serially section the entire tissue, which 
is essential to ensure that the center of each wound is assessed. In addition, standard histology 
only provides a snapshot through the wound and so it is unclear how consistent the evaluated 
region might be to other areas within the wound.  
Macroscopic assessment of wound closure forms the primary assessment for progression of 
healing in chronic wounds, given that biopsies may further jeopardize healing (18). Thus, 
current ex vivo models typically examine wound healing in an entirely different plane to 
“real-life” observations made in the clinic.  
Several recent studies have reported imaging the surface of ex vivo and organotypic wound 
cultures, using a range of different methods, which exploit differing spectroscopic properties 
of the various wound cell types. These include the use of infra-red and Raman spectroscopy 
(19), measuring UV auto-fluorescence (8), Magnetic Resonance Imaging (20), and revealing 
wound topography using fringe projection (21). In addition, the recent article in Wound 
Repair and Regeneration by Glinos et al (22) describes optical coherence tomography (OCT) 
as a method to differentiate newly formed epithelial tissue from open wound in human 
wounds ex vivo, and provides the highest clarity of imaging reported thus far.  
In our recent experiments we have established a serum-free ex vivo human partial thickness 
wound model (see methods for full details). We have been examining the green fluorescent 
cell tracker dye 5-chloromethylfluorescein diacetate (CMFDA), which is taken up by viable 
cells in culture (14), permitting lineage tracing experiments to understand the wound re-
epithelialization process in human skin. Moreover, dye uptake  can also be visualised under 
an upright fluorescent microscope (23), and using this simple approach we have optimized a 
method to produce a high clarity of wound imaging approaching cellular levels of resolution. 
We have for the first time been able to track daily wound re-epithelialization changes of 
individual human wounds ex vivo over six days. Our study provides a simple assay that can 
evaluate drug responses in human wounds ex vivo, where the study of healing progression 
can be made longitudinally.  
 
 
 
 
Methods 
Human skin was obtained with informed written consent from female donors undergoing 
elective abdominal surgery and conducted at the University of Manchester following 
institutional ethical review.  
Subcutaneous fat was removed and six millimetre diameter full thickness skin biopsies were 
taken, containing a 2 mm diameter partial thickness wound, removing the epidermis and 
papillary dermis (Figure 1A). Any explants displaying an inconsistent size or depth of wound 
were excluded prior to culture. Explants were cultured at an air-liquid interface by placing 
each explant in a 6 well plate upon two absorbent pads (Millipore, Ireland) and a 0.45µM 
nylon membrane (Millipore, Ireland) (Figure 1B). 2 ml of William’s E media (Life 
Technologies) supplemented with 1% Penicillin/Streptomycin, 2 mM L-Glutamine, 10 
µg/mL Insulin and 10ng/ml hydrocortisone (all supplements from Sigma-Aldrich, USA) was 
added to each well. Positive control explants were cultured with 10% Fetal Bovine Serum 
(FBS; Life technologies, UK) supplemented to the media. Cultures were grown at 37°C with 
5% CO2. Each day excess media was removed from the well and replaced with 1 mL fresh 
media.  
4µl of 25µM CMFDA (or CMTPX) (ThermoFisher Scientific, UK) was added to the wound 
surface for 30 minutes, then washed dropwise with PBS. For cell viability studies 1µg/ml of 
Propidium Iodide was co-treated alongside CMFDA. Planimetric imaging was conducted 
using a Leica M205 FA upright Stereomicroscope using a [5x / 0.50 pLANapo LWD] 
objective at the equivalent of [64x] magnification and captured using a [DFC 565FX (Leica)] 
camera through LAS AF v3.1.0.8587 software (Leica). Specific band pass filter set for GFP 
was used. (Leica, Germany) (Figure 1C).  
For wound closure experiments fluorescent imaging with CMFDA was conducted daily. 
Fluorescent images were assessed using Image J (Fiji) for the area of the initial wound at day 
0 (IW0). On subsequent days (where day is denoted by n) the area of initial wound (IWn), and 
the area of open wound remaining (OWn) was measured (see Figure S1A).  Epithelial wound 
closure was calculated from measurements of area of initial wound and the open wound 
remaining and expressed either as the % of wound closure on each day, or on the area of 
healing achieved on each day in mm2. Percentage closure = 100 - (OWn / IW0 x 100). Area 
healed = IW0 - OWn. Tissue contraction was calculated by assessing changes to the initial 
wound defect over the wound healing period. Tissue contraction = 100 – (IWn / IW0 x 100). 
In addition, the neo-epidermis was further assessed by measuring the area of the dim band of 
epidermal tissue towards the migrating front and the remaining brighter area (Figure S1A). 
Tissue from 5 individual donors was used, with 3-4 explants per donor used for each 
treatment. The mean value of the 3-4 replicate explants per donor used for analysis (i.e. 
assessed as n=5 replicate experiments from separate donors). A two-way ANOVA with 
repeated measures was used to analyse percentage wound closure, area healed and 
contraction between FBS and control groups, over the 6 days in culture. This analysis 
allowed for a statistical evaluation of differences in healing due to timepoint, or treatment 
group. In addition, the interaction between the two processes determined whether the 
evolution of healing response over time differed between treatment group. Our analysis 
makes the assumption that our data are normally distributed. 
Comparisons of % closure at an individual timepoint (day 2 or day 4) was assessed via a 
paired t test (GraphPad Prism 7.0, San Diego, CA). For all tests p<0.05 was considered 
significant. 
For histological imaging tissue was formalin fixed for 24hrs and processed for paraffin wax 
embedding. 5µm sections were cleared with Xylene and rehydrated to water, then either 
stained with DAPI (Fluorescence microscopy) or H&E (brightfield). Immuno-labelling with 
anti-keratin 1 (Abcam; Ab81623), anti-Involucrin (Abcam; Ab53112), anti-Occludin 
(Abcam; 168986) and anti-Loricrin (Abcam; Ab85679) antitobodies- was performed at 
1:1000 (keratin 1, Loricrin, Involucrin) or 1:250 (Occludin) dilution overnight at 4oC 
following heat mediated retrieval with 10mM Sodium Citrate pH6.0 and blocking with 10% 
goat serum for 30mins. Localisation was visualised with AlexaFluor594 tagged goat anti-
mouse (keratin 1) or goat anti-rabbit (Occludin, Involucrin, Loricrin) secondary antibody 
(Invitrogen), with DAPI counterstaining. Images of stained sections were captured using a 
BZ-9000 microscope (Keyence, Japan). 
 
 
Results 
Vital dyes label epithelial cells within wounds and reveal cellular migration patterns 
during repair 
To examine cell tracker dye uptake within human ex vivo wounds in situ we first conducted 
histology to validate our approach, using wounds treated topically at day 0 with the green live 
cell tracker dye CMFDA. In addition, given CMFDA should only mark viable cells the 
membrane impermeable nuclear dye Propidium Iodide (PI) was co-treated to identify any 
cells with damaged plasma membranes. Our data shows that only epithelial cells around the 
edge of the wound are labelled (Figure 2A). We do observe some PI +ve nuclei directly at the 
injury site, which do not express CMFDA. A band of CMFDA labels both basal and supra-
basal epidermal cells adjacent to the wound, extending several cells away from the injury site. 
When these treated wounds were cultured until day 1 we did not find any PI+ve nuclei 
remaining within the wound epidermis (Figure 2B). We find that Day 0 CMFDA labelled 
cells trace to the suprabasal portion of the emerging epithelial tongue on day 1, with the basal 
neo-epidermal cells were entirely unlabelled (Figure 2C), though these cells are able to 
uptake CMFDA when dye is treated on day 1 before harvesting (Figure 2C). Tracing 
CMFDA for longer reveals that the label becomes restricted to a portion of the outermost 
neo-epidermis towards the periphery of the wound (Figure 2C).   Wounds treated on day 0 
with CMFDA and then at day 1 with an equivalent red cell tracker dye CMTPX, confirms 
that cells at the tip of the epidermal front on day 1 are those not labelled on day 0 (Figure 2D 
and inset 1). Moreover, in the region proximal to wound edge the CMTPX is restricted to the 
outermost surface of the neo-epidermis, where some overlap to those cells labelled on day 0 
is observed (Figure 2D and insets 2 & 3). Occasionally, a few cells labelled on day 0 can be 
observed at late stages in the neo-epidermis and frequently these have a dendritic morphology 
(Figure 2E). Collectively, our data indicate that the basal cells present in close proximity to 
the injury at day 0 are selected to undergo maturation, while basal cells of the neo-epidermis 
were comprised of cells that were initially further away from the wound (Figure 2F). These 
data show strong agreement with an “extending shield mechanism” for epithelial repair as 
reported in skin equivalent wounds (14).  
 
 
 
Fluorescent vital dye can longitudinally monitor wound closure of human ex vivo 
wounds 
Over the course of our cell tracing experiments we found that using daily treatments of 
CMFDA the entire surface of the neo-epidermis becomes labelled (Figure 3A). With this 
labelling approach we then optimised a method to visualise the CMFDA stained wound tissue 
of explants in culture, using an upright fluorescent microscope (see methods and Figure 1C). 
This technique differentiated the neo-epidermis from areas of open wound and the 
surrounding unwounded tissue, without the need for histology (Figure 3B). The newly laid 
epidermis of these wounds in culture is not obvious using conventional brightfield 
microscope (Figure S1B).  
 
Using daily CMFDA treatments we conducted en face imaging to monitor wound closure 
within individual wounds over 6 days (Figure 3C). Moreover, we compared our standard 
serum-free explants (Control; CTL) to those cultured in the presence of 10% Fetal Bovine 
serum (FBS), to determine whether significantly accelerated repair could be correctly 
detected in our model (3).  
Our data not only show that epithelial healing can be monitored daily intra-vitally, but reveal 
a clear divergence in the evolution of repair with the addition of FBS (i.e. the interaction 
between time and treatment factors), when we evaluate the % epithelial closure (Figure 3D), 
or the area of healed epidermis (Figure 3E). Measuring the explants each day also revealed 
that some wound contraction occurs over time (Figure 3F). However, this only accounts for 
around 20% of total healing observed, indicating that re-epithelialisation provides the major 
healing mechanism. The level of contraction between control and FBS treated wounds was 
unchanged (Figure 3F). 
We observe that the rate of healing between individual donors is variable; although a 
response to FBS was reproducible and can detect significant differences to healing at 
individual timepoints, confirming the reliability of the model (Figure 3G).  
 
Regions of newly laid and more mature epidermis can be determined  
Our daily imaging identified distinct areas of epidermal healing with a band of dim 
expression towards the epidermal front, with brighter areas nearer to the margin (Figure 4A). 
As the CMFDA dye accumulates over time with our daily dosing regimen, and based on our 
observations with CMFDA and CMPTX dual labelling (Figure 2), we hypothesized that 
bright regions indicated cells that had been labelled early (and probably several times), while 
dim areas likely reflected newly laid tissue that were not labelled until a late timepoint. We 
therefore wondered if these areas could define cornified and non-cornified regions of the 
healing epidermis, as recently described to occur in human ex vivo wounds (22).  To further 
explore this we conducted histology of serial sections to compare H&E morphology to the 
CMFDA intensity, where we find that the bright cells show a granular appearance, while 
stratum corneum can often also be identified within the neo-epidermis within the CMFDA 
bright cell population (Figure 4B). Next, we conducted immunofluorescence for the 
suprabasal keratinocyte marker keratin 1, confirming that the front of epithelial healing was 
devoid Keratin 1+ve keratinocytes, while within the dim region Keratin 1 +ve cells emerged 
in the supra-basal layer, suggesting that cell differentiation commences relatively quickly 
(Figure 4C). The brighter region showed continuous expression of Keratin 1 within the supra-
basal layer, indicating that early differentiation had already completed by this point. We also 
stained wounds for later stages of epithelial differentiation. We find Involucrin, or Occludin 
were absent from the tip of healing, but again present in both dim and bright regions, though 
often looked less well organised in the dim region (Figure 4D). The cornified envelope 
marker Loricrin was never found in dim regions, but was sometimes detected towards the 
boundary of the bright region (Figure 4D). Collectively these data indicate that the brighter 
region contained a more organised epidermis.  
We quantified these dim and bright regions in our serum-free and 10%FBS treated explants, 
where we find that while the dim and bright regions are both significantly altered by time, 
though we find no statistically significant change between treatments (Figure 4E).   
 
 
Discussion 
Our data and other recent studies (8, 22) highlight the major advantage of ex vivo models 
incorporating partial thickness wounds, where complete re-epithelialization across the 
underlying dermal matrix can now be studied in real time in situ. Our data shows that non-
invasive fluorescent imaging can be employed to longitudinally examine ex vivo wounds for 
several healing parameters (tissue contraction, re-epithelialisation, epidermal maturation). 
This may be particularly important for revealing where an intervention alters only some 
aspects of repair. Our approach may enable researchers to quickly identify which timepoints 
or healing processes would be most instructive for a subsequent more in depth assessment. 
Furthermore, given the variable level of healing between donors it may be possible to use 
vital dyes to monitor healing progression of cultures. For example, instead of assessing on a 
particular day, researchers can harvest tissue once the desired level of repair has occurred. 
Examining wounds once the control group shows 50% healing would ensure that both 
positive or negative drug effects to the rate of healing can be quantified. It warrants further 
investigation to determine whether CMFDA en face imaging could be applied to other 
translational wound healing models such as porcine ex vivo skin wounds, or wound 
organotypic human skin constructs. 
While our study has utilised CMFDA and CMTPX, there are several other vital dyes that 
could be employed for labelling cells within the neo-epidermis (23-28). Moreover, by 
combining fluorescent dyes of different wavelengths we demonstrate that the possibility 
exists to follow cell migration patterns during ex vivo healing. Our data using cell tracing 
suggests that re-epithelialization occurs using the extending shield mechanism previously 
reported for organotypic wounds (14). This is important as skin equivalent models are highly 
simplified and it is unclear how well they replicate human in vivo wounds (16). Our data do 
reveal that a few rare cells labelled on day 0 can persist within the neo-epidermis at late 
stages of repair. The exact origin of these cells is unclear given that our CMFDA treatment 
on day 0 will also label cells within the dermis. However, the dendritic morphology suggests 
that they are unlikely to be keratinocytes, which alongside fibroblasts are the only two cell 
types typically found in artificial skin constructs.    
 
 
One important conclusion of the recent Glinos et al study is that experimental (i.e. circular) 
wounds often show different rates of healing within different areas of the same wound, a 
phenomenon that is unappreciated due to the use of histology in examining ex vivo repair. We 
also frequently observe irregular healing in different regions of a single wound (Figure 4A), 
with areas displaying especially pronounced centripetal migration (Figure 4A inset). 
However, at this stage we are not able to pinpoint the factors that are most critical for this. 
This finding is particularly important as histology of some wounds might achieve an entirely 
different result depending upon the plane of sectioning, further advocating en face imaging 
techniques in future studies.  
Despite this, histology remains an essential tool for researchers in this field in order to 
understand what is happening below the wound surface, or investigating wound responses 
such as proliferation, or activation of target genes. However, combining a non-invasive 
assessment for global wound closure, followed by end-point histology will maximise data 
obtained. Advanced imaging techniques constitutes an exciting methodological advance in 
wound healing research, particularly OCT which holds the prospect of being directly applied 
to investigate patient wounds (29, 30). While OCT currently remains prohibitively expensive 
for most ex vivo studies, CMFDA or other approaches like UV auto-fluorescence (8) may be 
a valid alternative as suitable equipment will be more readily available. The persistence of 
CMFDA within histological specimens may be especially instructive to pinpoint the wound 
margins, which may further aid histological assessment.  
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Figure Legends 
Figure 1. Methodology for wounded ex vivo skin assay and fluorescent imaging.  
Human skin explants of 6mm diameter are established with a partial thickness 2mm wound 
(A). Explants were cultured in air, elevated on absorbent pads and nourished with serum-free 
media (B). Imaging of the wound surface can be achieved via a simple protocol using 
fluorescent vital cell dye uptake and fluorescence microscopy (C). 
 
Figure 2. Epithelial repair of human ex vivo wounds progresses via an extending shield 
mechanism 
Human ex vivo wounds were cultured in the presence of the fluorescent dyes. CMFDA and 
Propidium Iodide (PI) co-treatment at time of injury (D0) identifies live (CMFDA; green) 
and dead (PI; red) cells around the injury site (A), and these wounds traced to day 1 indicate 
PI labelled cells are no longer present (B). CMFDA was treated at different times to examine 
how epithelial cells migrate, indicating that basal cells labelled on day 0 become 
progressively suprabasal. Treating with CMFDA on day 0 and on day 1 (inset 1) with the red 
cell tracker CMTPX reveals previously unlabelled cells at the epidermal tip (C). Labelled 
cells with a dendritic morphology were occasionally found in the neo-epidermis at later 
timepoints (E). Our data suggest an extending shield mechanism of repair whereby basal cells 
migrate from the surrounding epidermis (F). Bar =100µm (A-D), 20µm (E and inset images). 
Dotted line denotes basement membrane.  
 
Figure 3. Daily en face fluorescent images longitudinally assesses epithelial healing  
Daily treatments of human ex vivo wounds with CMFDA labelled the entire length of neo-
epidermis (A), which could also be visualised in en face images using an upright fluorescent 
microscope (B). Wounds cultured with 10% Fetal Bovine Serum (FBS) compared to standard 
media control arm were examined with daily en face imaging to track epithelial formation 
over time (C). Quantification revealed a significant acceleration with FBS in the % epithelial 
closure (D), and the area of neo-epidermis (E). Slight contraction was observed of the 
wounds in culture, although there was no difference between FBS or control wounds (F). 
Paired analysis demonstrates the variability in healing between donors, but that the FBS 
response is reproducible (G). Data in D-F analysed using 2 way ANOVA with repeated 
measures, while G used a paired t test. Graphs show mean +/- SEM in D-F and in G the mean 
of each individual donor (n=5 donors). * P<0.05, *** P<0.001, **** P<0.0001. Bar = 1mm 
(A), 100µm (B) and 500µm (C). 
 
Figure 4. CMFDA en face imaging identifies regions of neo-epidermis with bright and 
dim expression  
Daily en face imaging shows regions of dim and bright CMFDA intensity (A). Histology 
identifies mature stratified neo-epidermis at the edge of the band of bright epidermis (white 
arrow) (B). Immunofluorescence for Keratin 1 suggests epithelial differentiation has 
commenced within the dim region (C). Later stage markers of differentiation suggest that 
with exception of the epithelial tip both the bright and dim epidermis shows evidence of 
differentiation occurring, although the cornified cell envelope marker was only found at the 
very edge of the bright region (D). Quantification of the area of dim and bright regions 
revealed a significant change over time, but no significant difference upon FBS treatment (E). 
Graphs in E show mean with error expressed as SEM, data analysed using two way ANOVA 
with repeated measures. Bar = 500µm (A) and 100µm (B-D). * P<0.05, **** P<0.0001.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
